JF
STLN

Jump Financial’s Starling Oncology Institute, Inc. Common Stock STLN Stock Holding History

Jump Financial’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$357K Buy
116,430
+91,151
+361% +$280K ﹤0.01% 1407
2025
Q4 		$90K Sell
25,279
-58,121
-70% -$216K ﹤0.01% 1833
2025
Q3 		$291K Buy
+83,400
New +$286K ﹤0.01% 1489

Other funds holding STLN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KWM
Kanen Wealth Management Coconut Creek, Florida $278M AUM 38.85% 1-Year Est. Return
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.88% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jump Financial's STLN Position: Q1 2026 in Review

Jump Financial increased its Starling Oncology Institute, Inc. Common Stock (STLN) stake by 361% in Q1 2026, buying an estimated $280K and bringing the position to 116,430 shares worth $357K. The position accounts for ﹤0.01% of the portfolio, ranked #1407.

Jump Financial first reported a position in STLN in Q3 2025 and has held it in 3 quarters since. 115 funds tracked by Wall St. Rank hold STLN as of Q1 2026.

  • Jump Financial held 116,430 shares of Starling Oncology Institute, Inc. Common Stock worth $357K as of Q1 2026.
  • Jump Financial bought 91,151 Starling Oncology Institute, Inc. Common Stock shares in Q1 2026, an estimated $280K.
  • Starling Oncology Institute, Inc. Common Stock made up ﹤0.01% of Jump Financial's portfolio in Q1 2026, its #1407 holding.
  • Jump Financial first reported a position in Starling Oncology Institute, Inc. Common Stock in Q3 2025 and has held it in 3 quarters since.
  • 115 funds tracked by Wall St. Rank held Starling Oncology Institute, Inc. Common Stock as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.